<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36612505</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>09</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-4601</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>23</Day></PubDate></JournalIssue><Title>International journal of environmental research and public health</Title><ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation></Journal><ArticleTitle>Network Analysis of Neurobehavioral Symptom Patterns in an International Sample of Spanish-Speakers with a History of COVID-19 and Controls.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">183</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph20010183</ELocationID><Abstract><AbstractText>(1) Background: Psychometric network analysis provides a novel statistical approach allowing researchers to model clusters of related symptoms as a dynamic system. This study applied network analysis to investigate the patterns of somatic, cognitive, and affective neurobehavioral symptoms in an international sample of Spanish-speaking individuals with a history of COVID-19 positivity and non-COVID controls; (2) methods: the sample (n = 1093) included 650 adults from 26 countries who reported having previously tested positive for COVID-19 (COVID+) through a viral and/or antigen test (average of 147 days since diagnosis). The control group (COVID-) was comprised of 443 adults from 20 countries who had completed the survey prior to the COVID-19 pandemic; (3) results: relative to the COVID- network, the COVID+ network was very well-connected, such that each neurobehavioral symptom was positively connected to the network. The organize-to-headache and dizzy-to-balance connections in the COVID+ network were stronger than in the COVID- network. The hearing, numbness, and tense symptoms were more central to the COVID+ network with the latter connected to the sleep, fatigue, and frustrated symptoms. The COVID- network was largely disjointed, with most of the somatosensory symptoms forming their own cluster with no connections to other symptom groups and fatigue not being connected to any other symptom. The cognitive and affective symptoms in the COVID- network were also largely connected to symptoms from within their own groups; (4) conclusions: These findings suggest that many of the long-term neurobehavioral symptoms of COVID-19 form a discernable network and that headaches, frustration, hearing problems, forgetfulness, and tension are the most central symptoms. Cognitive and behavioral rehabilitation strategies targeting these central symptom network features may hold promise to help fracture the lingering symptom network of COVID-19.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Perrin</LastName><ForeName>Paul B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>School of Data Science, University of Virginia, 400 Brandon Ave., Charlottesville, VA 22903, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychology, University of Virginia, 485 McCormick Rd., Charlottesville, VA 22903, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Central Virginia Veterans Affairs Health Care System, 1201 Broad Rock Blvd, Richmond, VA 23249, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramos-Usuga</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Biomedical Research Doctorate Program, University of the Basque Country, Barrio Sarriena, s/n, 48940 Leioa, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biocruces Bizkaia Health Research Institute, Cruces Plaza, 48903 Barakaldo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>West</LastName><ForeName>Samuel J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Psychology, Virginia State University, 1 Hayden St., Petersburg, VA 23803, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merced</LastName><ForeName>Kritzia</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-2293-7614</Identifier><AffiliationInfo><Affiliation>Central Virginia Veterans Affairs Health Care System, 1201 Broad Rock Blvd, Richmond, VA 23249, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Psychology and Physical Medicine and Rehabilitation, Virginia Commonwealth University, 907 Floyd Ave., Richmond, VA 23284, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klyce</LastName><ForeName>Daniel W</ForeName><Initials>DW</Initials><AffiliationInfo><Affiliation>Central Virginia Veterans Affairs Health Care System, 1201 Broad Rock Blvd, Richmond, VA 23249, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Psychology and Physical Medicine and Rehabilitation, Virginia Commonwealth University, 907 Floyd Ave., Richmond, VA 23284, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lequerica</LastName><ForeName>Anthony H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Center for Traumatic Brain Injury Research, Kessler Foundation, 120 Eagle Rock Avenue, East Hanover, NJ 07936, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olabarrieta-Landa</LastName><ForeName>Laiene</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-8305-8720</Identifier><AffiliationInfo><Affiliation>Health Sciences Department, Public University of Navarre (UPNA), Catalu&#xf1;a, s/n, 31006 Pamplona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alzueta</LastName><ForeName>Elisabet</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-2770-2104</Identifier><AffiliationInfo><Affiliation>Center for Health Sciences, SRI International, 333 Ravenswood Ave, Menlo Park, CA 94025, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baker</LastName><ForeName>Fiona C</ForeName><Initials>FC</Initials><AffiliationInfo><Affiliation>Center for Health Sciences, SRI International, 333 Ravenswood Ave, Menlo Park, CA 94025, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brain Function Research Group, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iacovides</LastName><ForeName>Stella</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Brain Function Research Group, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cortes</LastName><ForeName>Mar</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2828-8504</Identifier><AffiliationInfo><Affiliation>Department of Rehabilitation and Human Performance, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arango-Lasprilla</LastName><ForeName>Juan Carlos</ForeName><Initials>JC</Initials><Identifier Source="ORCID">0000-0002-7184-8311</Identifier><AffiliationInfo><Affiliation>Departments of Psychology and Physical Medicine and Rehabilitation, Virginia Commonwealth University, 907 Floyd Ave., Richmond, VA 23284, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Environ Res Public Health</MedlineTA><NlmUniqueID>101238455</NlmUniqueID><ISSNLinking>1660-4601</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035061" MajorTopicYN="N">Control Groups</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006261" MajorTopicYN="N">Headache</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011594" MajorTopicYN="N">Psychometrics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004244" MajorTopicYN="N">Dizziness</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">network analysis</Keyword><Keyword MajorTopicYN="N">neurobehavioral symptoms</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>8</Day><Hour>1</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36612505</ArticleId><ArticleId IdType="pmc">PMC9819652</ArticleId><ArticleId IdType="doi">10.3390/ijerph20010183</ArticleId><ArticleId IdType="pii">ijerph20010183</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Callard F., Perego E. How and why patients made Long Covid. Soc. Sci. Med. 2021;268:113426. doi: 10.1016/j.socscimed.2020.113426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahase E. COVID-19: What do we know about &#x201c;long covid&#x201d;? BMJ. 2020;370:m2815. doi: 10.1136/bmj.m2815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m2815</ArticleId><ArticleId IdType="pubmed">32665317</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC  Post-COVID Conditions. Centers for Disease Control and Prevention. Published 17 September 2021.  [(accessed on 7 January 2022)]; Available online:  https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html.</Citation></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugon J., Msika E.-F., Queneau M., Farid K., Paquet C. Long COVID: Cognitive complaints (brain fog) and dysfunction of the cingulate cortex. J. Neurol. 2022;269:44&#x2013;46. doi: 10.1007/s00415-021-10655-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10655-x</ArticleId><ArticleId IdType="pmc">PMC8211714</ArticleId><ArticleId IdType="pubmed">34143277</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker J.H., Lin J.J., Doernberg M., Stone K., Navis A., Festa J.R., Wisnivesky J.P. Assessment of Cognitive Function in Patients After COVID-19 Infection. JAMA Netw. Open. 2021;4:e2130645. doi: 10.1001/jamanetworkopen.2021.30645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.30645</ArticleId><ArticleId IdType="pmc">PMC8536953</ArticleId><ArticleId IdType="pubmed">34677597</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C., Laurent E., Lemaignen A., Beaufils E., Bourbao-Tournois C., Laribi S., Flament T., Ferreira-Maldent N., Bruy&#xe8;re F., Stefic K., et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin. Microbiol. Infect. 2021;27:258&#x2013;263. doi: 10.1016/j.cmi.2020.09.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M., Braillard O., Alcoba G., Perone S.A., Courvoisier D., Chappuis F., Guessous I. COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings. Ann. Intern. Med. 2021;174:723&#x2013;725. doi: 10.7326/M20-5926.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5926</ArticleId><ArticleId IdType="pmc">PMC7741180</ArticleId><ArticleId IdType="pubmed">33284676</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V., Flanders S.A., O&#x2019;Malley M., Malani A.N., Prescott H.C. Sixty-Day Outcomes Among Patients Hospitalized With COVID-19. Ann. Intern. Med. 2021;174:576&#x2013;578. doi: 10.7326/M20-5661.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5661</ArticleId><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal M., Omirah M.A., Hussein A., Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int. J. Clin. Pract. 2021;75:e13746. doi: 10.1111/ijcp.13746.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.13746</ArticleId><ArticleId IdType="pmc">PMC7536922</ArticleId><ArticleId IdType="pubmed">32991035</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J.R., Husain M., Luciano S., Harrison P.J. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: A retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;427. doi: 10.1016/S2215-0366(21)00084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E., Janvier P., Kherabi Y., Le Bot A., Hamon A., Gouze H., Doucet L., Berkani S., Oliosi E., Mallart E., et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J. Infect. 2020;81:e4&#x2013;e6. doi: 10.1016/j.jinf.2020.08.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>de Freitas R.F., Torres S.C., Mart&#xed;n-S&#xe1;nchez F.J., Carb&#xf3; A.V., Lauria G., Nunes J.P.L. Syncope and COVID-19 disease&#x2014;A systematic review. Auton. Neurosci. 2021;235:102872. doi: 10.1016/j.autneu.2021.102872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2021.102872</ArticleId><ArticleId IdType="pmc">PMC8393505</ArticleId><ArticleId IdType="pubmed">34500351</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu T.M., Seet C.Y.H., Koh J.S., Tham C.H., Chiew H.J., De Leon J.A., Chua C.Y.K., Hui A.C.-F., Tan S.S.Y., Vasoo S.S., et al. Acute Ischemic Stroke During the Convalescent Phase of Asymptomatic COVID-2019 Infection in Men. JAMA Netw. Open. 2021;4:e217498. doi: 10.1001/jamanetworkopen.2021.7498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.7498</ArticleId><ArticleId IdType="pmc">PMC8063067</ArticleId><ArticleId IdType="pubmed">33885771</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubair A.S., McAlpine L.S., Gardin T., Farhadian S., Kuruvilla D.E., Spudich S. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review. JAMA Neurol. 2020;77:1018&#x2013;1027. doi: 10.1001/jamaneurol.2020.2065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.2065</ArticleId><ArticleId IdType="pmc">PMC7484225</ArticleId><ArticleId IdType="pubmed">32469387</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullaguri N., Sivakumar S., Battineni A., Anand S., Vanderwerf J. COVID-19 Related Acute Hemorrhagic Necrotizing Encephalitis: A Report of Two Cases and Literature Review. Cureus. 2021;13:e14236. doi: 10.7759/cureus.14236.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.14236</ArticleId><ArticleId IdType="pmc">PMC8087949</ArticleId><ArticleId IdType="pubmed">33948421</ArticleId></ArticleIdList></Reference><Reference><Citation>Naz S., Hanif M., Haider M.A., Ali M.J., Ahmed M.U., Saleem S. Meningitis as an Initial Presentation of COVID-19: A Case Report. Front. Public Health. 2020;8:474. doi: 10.3389/fpubh.2020.00474.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.00474</ArticleId><ArticleId IdType="pmc">PMC7536294</ArticleId><ArticleId IdType="pubmed">33072684</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuroda N. Epilepsy and COVID-19: Updated evidence and narrative review. Epilepsy Behav. 2021;116:107785. doi: 10.1016/j.yebeh.2021.107785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yebeh.2021.107785</ArticleId><ArticleId IdType="pmc">PMC7805398</ArticleId><ArticleId IdType="pubmed">33515934</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan F., Sharma P., Pandey S., Sharma D., V. V., Kumar N., Shukla S., Dandu H., Jain A., Garg R.K., et al. COVID-19-associated Guillain-Barre syndrome: Postinfectious alone or neuroinvasive too? J. Med. Virol. 2021;93:6045&#x2013;6049. doi: 10.1002/jmv.27159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27159</ArticleId><ArticleId IdType="pmc">PMC8426929</ArticleId><ArticleId IdType="pubmed">34170552</ArticleId></ArticleIdList></Reference><Reference><Citation>Crunfli F., Carregari V.C., Veras F.P., Vendramini P.H., Valen&#xe7;a A.G.F., Antunes A.S.L.M., Brand&#xe3;o-Teles C., da Silva Zuccoli G., Reis-de-Oliveira G., Silva-Costa L.C., et al. SARS-CoV-2 infects brain astrocytes of COVID-19 patients and impairs neuronal viability. MedRxiv. 2021 doi: 10.1101/2020.10.09.20207464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.09.20207464</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews M.G., Mukhtar T., Eze U.C., Simoneau C.R., Ross J., Parikshak N., Wang S., Zhou L., Koontz M., Velmeshev D., et al. Tropism of SARS-CoV-2 for developing human cortical astrocytes. Proc. Natl. Acad. Sci. USA. 2022;119:e2122236119. doi: 10.1073/pnas.2122236119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2122236119</ArticleId><ArticleId IdType="pmc">PMC9335272</ArticleId><ArticleId IdType="pubmed">35858406</ArticleId></ArticleIdList></Reference><Reference><Citation>Isacson O. The Consequences of Coronavirus-Induced Cytokine Storm Are Associated With Neurological Diseases, Which May Be Preventable. Front. Neurol. 2020;11:745. doi: 10.3389/fneur.2020.00745.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00745</ArticleId><ArticleId IdType="pmc">PMC7393211</ArticleId><ArticleId IdType="pubmed">32793108</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirunpattarasilp C., James G., Freitas F., Sethi H., Kittler J.T., Huo J., Owens R.J., Attwell D. SARS-CoV-2 binding to ACE2 triggers pericyte-mediated angiotensin-evoked cerebral capillary constriction. bioRxiv. 2021 doi: 10.1101/2021.04.01.438122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.04.01.438122</ArticleId><ArticleId IdType="pmc">PMC9384509</ArticleId><ArticleId IdType="pubmed">35867861</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi O.L., Hughes S.E., Turner G., Rivera S.C., McMullan C., Chandan J.S., Haroon S., Price G., Davies E.H., Nirantharakumar K., et al. Symptoms, complications and management of long COVID: A review. J. R. Soc. Med. 2021;114:428&#x2013;442. doi: 10.1177/01410768211032850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Benzakour L., Assal F., P&#xe9;ron J.A. Neuropsychological long-COVID: Neurologic or psychiatric origin? Rev. Med. Suisse. 2021;17:822&#x2013;826.</Citation><ArticleIdList><ArticleId IdType="pubmed">33908718</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A., Trender W., Chamberlain S.R., Jolly A.E., Grant J.E., Patrick F., Mazibuko N., Williams S.C., Barnby J.M., Hellyer P., et al. Cognitive deficits in people who have recovered from COVID-19. Eclinicalmedicine. 2021;39:101044. doi: 10.1016/j.eclinm.2021.101044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101044</ArticleId><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak K., Johnsen S., Sattler S., Nielsen S., Kunalan K., Rungby J., Lapperre T., Porsberg C. Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables. Eur. Neuropsychopharmacol. 2021;46:39&#x2013;48. doi: 10.1016/j.euroneuro.2021.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2021.03.019</ArticleId><ArticleId IdType="pmc">PMC8006192</ArticleId><ArticleId IdType="pubmed">33823427</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Lewis A., Melmed K., Lin J., Kondziella D., Helbok R., Yaghi S., Meropol S., Wisniewski T., Balcer L., et al. Prevalence and Predictors of Prolonged Cognitive and Psychological Symptoms following COVID-19 in the United States. Front. Aging Neurosci. 2021;13:357. doi: 10.3389/fnagi.2021.690383.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2021.690383</ArticleId><ArticleId IdType="pmc">PMC8326803</ArticleId><ArticleId IdType="pubmed">34349633</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonizzato S., Ghiggia A., Ferraro F., Galante E. Cognitive, behavioral, and psychological manifestations of COVID-19 in post-acute rehabilitation setting: Preliminary data of an observational study. Neurol. Sci. 2022;43:51&#x2013;58. doi: 10.1007/s10072-021-05653-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05653-w</ArticleId><ArticleId IdType="pmc">PMC8510572</ArticleId><ArticleId IdType="pubmed">34642823</ArticleId></ArticleIdList></Reference><Reference><Citation>Thye A.Y.-K., Law J.W.-F., Tan L.T.-H., Pusparajah P., Ser H.-L., Thurairajasingam S., Letchumanan V., Lee L.-H. Psychological Symptoms in COVID-19 Patients: Insights into Pathophysiology and Risk Factors of Long COVID-19. Biology. 2022;11:61. doi: 10.3390/biology11010061.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology11010061</ArticleId><ArticleId IdType="pmc">PMC8773222</ArticleId><ArticleId IdType="pubmed">35053059</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers J.P., Chesney E., Oliver D., Pollak T.A., McGuire P., Fusar-Poli P., Zandi M.S., Lewis G., David A.S. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: A systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7:611&#x2013;627. doi: 10.1016/S2215-0366(20)30203-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30203-0</ArticleId><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Fried E.I., Haslbeck J.M.B. Using network analysis to examine links between individual depression symptoms, inflammatory markers, and covariates. Psychol. Med. 2020;50:2682&#x2013;2690. doi: 10.1017/S0033291719002770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291719002770</ArticleId><ArticleId IdType="pubmed">31615595</ArticleId></ArticleIdList></Reference><Reference><Citation>Armour C., Fried E.I., Deserno M.K., Tsai J., Pietrzak R.H. A network analysis of DSM-5 posttraumatic stress disorder symptoms and correlates in U.S. military veterans. J. Anxiety Disord. 2017;45:49&#x2013;59. doi: 10.1016/j.janxdis.2016.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.janxdis.2016.11.008</ArticleId><ArticleId IdType="pubmed">27936411</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva M.A. Review of the Neurobehavioral Symptom Inventory. Rehabil. Psychol. 2021;66:170&#x2013;182. doi: 10.1037/rep0000367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/rep0000367</ArticleId><ArticleId IdType="pubmed">33119379</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicerone K.D., Kalmar K. Persistent post-concussive syndrome: Structure of subjective complaints after mild traumatic brain injury. Arch. Phys. Med. Rehabil. 1994;75:723. doi: 10.1016/0003-9993(94)90236-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0003-9993(94)90236-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Lequerica A.H., Arango-Lasprilla J.C., Krch D. Factor analysis of the Neurobehavioral Symptom Inventory among a sample of Spanish-speakers. Neuropsychol. Rehabil. 2020;32:165&#x2013;178. doi: 10.1080/09602011.2020.1809464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09602011.2020.1809464</ArticleId><ArticleId IdType="pubmed">32867569</ArticleId></ArticleIdList></Reference><Reference><Citation>Epskamp S., Borsboom D., Fried E.I. Estimating psychological networks and their accuracy: A tutorial paper. Behav. Res. Methods. 2018;50:195&#x2013;212. doi: 10.3758/s13428-017-0862-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.3758/s13428-017-0862-1</ArticleId><ArticleId IdType="pmc">PMC5809547</ArticleId><ArticleId IdType="pubmed">28342071</ArticleId></ArticleIdList></Reference><Reference><Citation>Epskamp S., Fried E.I. A tutorial on regularized partial correlation networks. Psychol. Methods. 2018;23:617&#x2013;634. doi: 10.1037/met0000167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/met0000167</ArticleId><ArticleId IdType="pubmed">29595293</ArticleId></ArticleIdList></Reference><Reference><Citation>Epskamp S., Cramer A.O.J., Waldorp L.J., Schmittmann V.D., Borsboom D. qgraph: Network Visualizations of Relationships in Psychometric Data. J. Stat. Softw. 2012;48:1&#x2013;18. doi: 10.18637/jss.v048.i04.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v048.i04</ArticleId></ArticleIdList></Reference><Reference><Citation>Golino H.F., Epskamp S. Exploratory graph analysis: A new approach for estimating the number of dimensions in psychological research. PLoS ONE. 2017;12:e0174035. doi: 10.1371/journal.pone.0174035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0174035</ArticleId><ArticleId IdType="pmc">PMC5465941</ArticleId><ArticleId IdType="pubmed">28594839</ArticleId></ArticleIdList></Reference><Reference><Citation>van Borkulo C.D., van Bork R., Boschloo L., Kossakowski J.J., Tio P., Schoevers R.A., Borsboom D., Waldorp L.J. Comparing network structures on three aspects: A permutation test. Psychol. Methods. 2022 doi: 10.1037/met0000476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/met0000476</ArticleId><ArticleId IdType="pubmed">35404628</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao T., Liu H., Roeder K., Lafferty J., Wasserman L. The huge Package for High-dimensional Undirected Graph Estimation in R. J. Mach. Learn. Res. 2012;13:1059&#x2013;1062.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4729207</ArticleId><ArticleId IdType="pubmed">26834510</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallus R., Melis A., Rizzo D., Piras A., De Luca L.M., Tramaloni P., Serra A., Longoni E., Soro G.M., Bussu F. Audiovestibular symptoms and sequelae in COVID-19 patients. J. Vestib. Res. 2021;31:381&#x2013;387. doi: 10.3233/VES-201505.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/VES-201505</ArticleId><ArticleId IdType="pubmed">33579886</ArticleId></ArticleIdList></Reference><Reference><Citation>Badenoch J.B., Rengasamy E.R., Watson C., Jansen K., Chakraborty S., Sundaram R.D., Hafeez D., Burchill E., Saini A., Thomas L., et al. Persistent neuropsychiatric symptoms after COVID-19: A systematic review and meta-analysis. Brain Commun. 2022;4:fcab297. doi: 10.1093/braincomms/fcab297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcab297</ArticleId><ArticleId IdType="pmc">PMC8833580</ArticleId><ArticleId IdType="pubmed">35169700</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L., Kannapadi N.V., Briggs J., Seal S.M., Battaglini D., Fanning J., Suen J., Robba C., Fraser J., Cho S.-M. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J. Neurol. Sci. 2022;434:120162. doi: 10.1016/j.jns.2022.120162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan K., Miller A.K., Reiter K., Bonner-Jackson A. Neurocognitive Profiles in Patients with Persisting Cognitive Symptoms Associated with COVID-19. Arch. Clin. Neuropsychol. 2022;37:729&#x2013;737. doi: 10.1093/arclin/acac004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/arclin/acac004</ArticleId><ArticleId IdType="pmc">PMC8903427</ArticleId><ArticleId IdType="pubmed">35136912</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukaetova-Ladinska E.B., Kronenberg G. Psychological and neuropsychiatric implications of COVID-19. Eur. Arch. Psychiatry Clin. Neurosci. 2020;271:235&#x2013;248. doi: 10.1007/s00406-020-01210-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-020-01210-2</ArticleId><ArticleId IdType="pmc">PMC7680256</ArticleId><ArticleId IdType="pubmed">33221936</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>